论文部分内容阅读
目的 :评价国产那格列奈片治疗 2型糖尿病的疗效。方法 :4 6例 2型糖尿病患者随机分入那格列奈组和瑞格列奈组 ,以瑞格列奈作阳性对照 ,检测空腹血糖及糖化血红蛋白 (HbA1C)。结果 :两组治疗后空腹指尖及静脉血糖、糖化血红蛋白均有所下降 ,治疗 8周后瑞格列奈组空腹指尖血糖改善值优于那格列奈组。结论 :那格列奈片能改善 2型糖尿病患者的糖代谢 ,是一种安全有效的降糖药物。
Objective: To evaluate the curative effect of domestic nateglinide on type 2 diabetes mellitus. Methods: Twenty-six patients with type 2 diabetes were randomly divided into nateglinide group and repaglinide group. Repaglinide was used as a positive control to detect fasting blood glucose and glycosylated hemoglobin (HbA1C). Results: The fasting fingertips, venous blood glucose and HbA1c decreased after treatment in both groups. After 8 weeks of treatment, the improvement of fasting fingertip blood glucose in repaglinide group was better than nateglinide group. Conclusion: Nateglinide tablets can improve glycometabolism in type 2 diabetic patients and is a safe and effective antidiabetic drug.